Ligation of macrophage FCγ receptors recapitulates the gene expression pattern of vulnerable human carotid plaques

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Lennartz, Michelle R ^a   Aggarwal, Ankur ^a   Michaud, Tanya M ^a   Feustel, Paul J ^a   Jones, David M ^a   Brosnan, M Julia ^b,d   Keller, Rebecca S ^a   Loegering, Daniel J ^a   Kreienberg, Paul B ^c  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ORDWAY RESEARCH INSTITUTE   (United States)

^c Institute for Vascular Health and Disease   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; FC RECEPTOR; FC RECEPTOR 1; FC RECEPTOR IIA; GELATINASE B; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN; MACROPHAGE ELASTASE; NEUTROPHIL COLLAGENASE; PROTEIN KINASE C THETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SCAVENGER RECEPTOR A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR; BIOLOGICAL MARKER; MESSENGER RNA;

AGED; ARTICLE; CAROTID ARTERY; CELL ACTIVATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FC GAMMA RECEPTOR I GENE; FC GAMMA RECEPTOR IIA GENE; FC GAMMA RECEPTOR III GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GP91 PHOX GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MALE; MMP1 GENE; MMP12 GENE; MMP8 GENE; MMP9 GENE; PKC TETA GENE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SR A GENE; STROKE; TIMP1 GENE; TIMP2 GENE; TIMP3 GENE; TNF ALPHA GENE; UPA GENE; UPAR GENE; ANTIGEN ANTIBODY COMPLEX; CAROTID ARTERY DISEASE; CYTOLOGY; FEMALE; GENETICS; LIGATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; FEMALE; HUMANS; LIGATION; MACROPHAGES; MALE; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79960629247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021803     Document Type: Article

References (29)

1. Vemuganti R, Dempsey RJ, (2005) Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience 131: 359-374.
2. ry HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15: 1512-1531.
3. Orbe J, Fernandez L, Rodríguez JA, Rábago G, Belzunce M, et al. (2003) Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 170: 269-276.
4. Galis ZS, Sukhova GK, Lark MW, Libby P, (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
5. Libby P, Ridker PM, Maseri A, (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
6. Mold C, Gresham HD, Du Clos TW, (2001) Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc-gammaRs. J Immunol 166: 1200-1205.
7. Virella G, Lopes-Virella MF, (2008) Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 200: 239-246.
8. Hernandez-Vargas P, Ortiz-Munoz G, Lopez-Franco O, Suzuki Y, Gallego-Delgado J, et al. (2006) Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 99: 1188-1196.
9. Kelly JA, Griffin ME, Fava RA, Wood SG, Bessette KA, et al. (2010) Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. Cardiovasc Res 85: 224-231.
10. Ranganathan AC, Nelson KK, Rodriguez AM, Kim KH, Tower GB, et al. (2001) Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J Biol Chem 276: 14264-14270.
11. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D, (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98: 1487-1494.
12. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D, (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 81: 3883-3887.
13. Larsen EC, Ueyama T, Brannock PM, Shirai Y, Saito N, et al. (2002) A role for PKC-varepsilon in FcgammaR-mediated phagocytosis by RAW 264.7 cells. J Cell Biol 159: 939-944.
14. Group ECSTC (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). The Lancet 351: 1379-1387.
15. Warlow C, (1991) MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. The Lancet 337: 1235-1243.
16. Collaborators NASCET (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325: 445-453.
17. Maxeiner H, Husemann J, Thomas CA, Loike JD, Khoury JE, et al. (1998) Complementary Roles for Scavenger Receptor A and CD36 of Human Monocyte-derived Macrophages in Adhesion to Surfaces Coated with Oxidized Low-Density Lipoproteins and in Secretion of H2O2. J Exp Med 188: 2257-2265.
18. Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, et al. (2003) Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study. Arterioscler Thromb Vasc Biol 23: 1444-1448.
19. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P, (1995) Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 748: 501-507.
20. Cuaz-Perolin C, Jguirim I, Larigauderie G, Jlassi A, Furman C, et al. (2006) Apolipoprotein E Knockout Mice Over-Expressing Human Tissue Inhibitor of Metalloproteinase 1 Are Protected against Aneurysm Formation but Not against Atherosclerotic Plaque Development. J Vasc Res 43: 493-501.
21. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
22. Edwards JP, Zhang X, Frauwirth KA, Mosser DM, (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80: 1298-1307.
23. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
24. Calverley DC, Varteresian T, Brass E, Tsao-Wei DD, Groshen S, et al. (2004) Association between monocyte Fcgamma subclass expression and acute coronary syndrome. Immun Ageing 1: 4.
25. van der Meer IM, Witteman JC, Hofman A, Kluft C, de Maat MP, (2004) Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study. Thromb Haemost 92: 1273-1276.
26. Loike JD, Shabtai DY, Neuhut R, Malitzky S, Lu E, et al. (2004) Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol. Arterioscler Thromb Vasc Biol 24: 2051-2056.
27. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, et al. (2004) Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24: 2137-2142.
28. Zhao M, Wigren M, Duner P, Kolbus D, Olofsson KE, et al. (2010) Fc{gamma}RIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. J Immunol 184: 2253-2260.
29. Mendez-Fernandez YV, Stevenson BG, Diehl CJ, Braun NA, Wade NS,et al. The inhibitory Fc[gamma]RIIb modulates the inflammatory response and influences atherosclerosis in male apoE-/- mice. Atherosclerosis 214: 73-80.